Abstract

BackgroundIn large health care systems, decision regarding broad implementation of psychotherapies for inpatients with psychosis require substantial evidence regarding effectiveness and feasibility for implementation. It is important to recognize challenges in conducting research to inform such decisions, including difficulties in obtaining consent from and engaging inpatients with psychosis in research. We set out to conduct a feasibility and effectiveness Hybrid Type I pilot randomized controlled trial of acceptance and commitment therapy (ACT) and a semi-formative evaluation of barriers and facilitators to implementation.FindingsWe developed a training protocol and refined an ACT treatment manual for inpatient treatment of psychosis for use at the Veterans Health Administration. While our findings on feasibility were mixed, we obtained supportive evidence of the acceptability and safety of ACT. Identified strengths of ACT included a focus on achievement of valued goals rather than symptoms. Weaknesses included that symptoms may limit patient’s understanding of ACT. Facilitators included building trust and multi-stage informed consent processes. Barriers included restrictive eligibility criteria, rigid use of a manualized protocol, and individual therapy format. Conclusions are limited by our randomization of only 18 patient participants (with nine completing all aspects of the study) out of 80 planned.ConclusionsFuture studies should include (1) multi-stage informed consent processes to build trust and alleviate patient fears, (2) relaxation of restrictions associated with obtaining efficacy/effectiveness data, and (3) use of Hybrid Type II and III designs.

Highlights

  • In large health care systems, decision regarding broad implementation of psychotherapies for inpa‐ tients with psychosis require substantial evidence regarding effectiveness and feasibility for implementation

  • Future studies should include (1) multi-stage informed consent processes to build trust and alleviate patient fears, (2) relaxation of restrictions associated with obtaining efficacy/effectiveness data, and (3) use of Hybrid Type II and III designs

  • Broad implementation of treatment for inpatients with psychosis, and of psychotherapies such as ACT, typically requires substantial evidence regarding effectiveness and feasibility of implementation. Such evidence is typically garnered from research studies. This is especially true within large health care systems, such as the Veterans Health Administration (VHA)

Read more

Summary

Introduction

In large health care systems, decision regarding broad implementation of psychotherapies for inpa‐ tients with psychosis require substantial evidence regarding effectiveness and feasibility for implementation. It is important to recognize challenges in conducting research to inform such decisions, including difficulties in obtaining consent from and engaging inpatients with psychosis in research. Health systems seek to deliver ongoing outpatient care to help patients maintain function and symptom stability This is difficult due to periodic exacerbations [5], low. Broad implementation of treatment for inpatients with psychosis, and of psychotherapies such as ACT, typically requires substantial evidence regarding effectiveness and feasibility of implementation. Such evidence is typically garnered from research studies. It is difficult to obtain consent and engage psychiatric inpatients with psychosis in research (e.g., [14])

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call